Navigation Links
ImaginAb, Inc. and Dainippon Seiki (DNS) Co., Ltd. Conclude Technology Development Agreement for Automated Chemistry Systems
Date:4/11/2011

LOS ANGELES and KYOTO, Japan, April 11, 2011 /PRNewswire/ -- ImaginAb, Inc. and Dainippon Seiki Co., Ltd. have concluded a technology agreement around the development of automated chemistry systems for fluorination of proteins and peptides for diagnostic imaging with positron emission tomography (PET).

"Over the past 18 months, our academic and pharma client base has dramatically increased and we have been developing and in-licensing novel fluorine chemistries to streamline labeling of proteins and peptides for targeted molecular imaging with PET," said Dr. Christian Behrenbruch, CEO of ImaginAb. "DNS has tremendous automation and instrumentation experience in the chemistry / radiochemistry domain and we are delighted to be working with such a dynamic and innovative organization to deliver new solutions to our customers."

Mr. Masayoshi Sugihara, President of DNS commented, "We have seen a significant increase in the interest level in novel peptides and biologics for diagnostic imaging and believe in the commercial importance of automated fluorine chemistry to drive this industry ahead. We are pleased to be collaborating with ImaginAb to develop high-throughput fluorination solutions that will be suitable for both pre-clinical and (eventually) clinical use."*

About ImaginAb

Founded in 2007 by UCLA Faculty (Drs. Robert Reiter, Anna Wu and Christian Behrenbruch), ImaginAb, Inc. is a biotechnology company specializing in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications. The company has a significant pipeline of clinical products in development oriented towards unmet needs in cancer and immunology. ImaginAb is also developing a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT and optical imaging systems, and partners on a selective basis with biopharmaceutical companies with an interest in developing companion imaging agents for therapeutic antibody products. For more information about ImaginAb, visit www.imaginab.com.

About DNS

Based in Kyoto, Japan, Dainippon Seiki (DNS) Co., Ltd. is an innovation leader in automation, robotics and high-precision instrumentation. DNS is a best-in-class provider of fully automated synthesis, diagnostic/inspection and robotic assembly systems with solutions for both life sciences/pharmaceutical and semiconductor industries. For more information about DNS, visit www.dnseiki.co.jp.

*The products and services described in this press release have not attained regulatory approval for clinical use in Japan or the USA.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Anna Wu

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=91513


'/>"/>
SOURCE ImaginAb, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImaginAb, Inc. and Eurogentec S.A. Collaborate to Produce Antibody Fragments in Pichia
2. ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration
3. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
4. Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease
5. Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
6. Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
7. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
8. Published Study Concludes: Vented Baby Bottles Protect Essential Nutrients in Breast Milk and Formula
9. Independent Study Concludes Medicare Competitive Bidding Program for Durable Medical Equipment Could Negatively Affect Care Access, Quality, and Choice for Seniors and People with Disabilities
10. Mr. Jean-Pierre Garnier Concludes his Mission at the Pierre Fabre Company
11. arGEN-X Concludes EUR 12.5 Million Series A Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... INDIANAPOLIS , Sept. 7, 2017  Eli ... today announced actions to streamline operations to more ... to improve its cost structure. Global workforce reductions, ... program, are expected to impact approximately 3,500 positions. ... the company expects annualized savings of approximately $500 ...
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... 6, 2017 Eli Lilly and Company (NYSE: ... new data for galcanezumab and lasmiditan, two investigational treatments ... Headache Society (IHC) taking place Sept. 7-10 in ... highlight new, long-term data from an open-label study evaluating ... (120 mg and 240 mg) for the prevention of ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... ... been officially recognized for its September 2016 donation of dog beds to the ... received three awards and honors for its contribution from city and state officials. ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... the success of the annual PAINWeek National Conference. On October 7, at the ... an educational and exciting program providing busy clinicians and allied healthcare practitioners with ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bone Solutions Inc. (BSI), ... magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist ... incorporate magnesium, a critical property for bone health and development. , “We’re excited ...
(Date:9/19/2017)... ... September 19, 2017 , ... Premiere Long Island dental office Gold Coast Smiles ... of the best dentists in America under age 40 by Incisal Edge magazine. ... the magazine features the best 40 dentists under the age of 40 renowned for ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... , the most prestigious ranking of the nation's fastest-growing private companies. The list ... most dynamic segment— its independent small and midsized businesses. Endo-Systems is a leading ...
Breaking Medicine News(10 mins):